Northern Trust
NVCT icon

Northern Trust’s Nuvectis Pharma NVCT Stock Holding History

Northern Trust’s Portfolio NVCT Stock Details NVCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$960K Buy
124,212
+7,807
+7% +$66.9K ﹤0.01% 3361
2025
Q4 		$879K Buy
116,405
+9,764
+9% +$63.7K ﹤0.01% 3441
2025
Q3 		$642K Sell
106,641
-3,176
-3% -$21.8K ﹤0.01% 3566
2025
Q2 		$820K Buy
109,817
+71,759
+189% +$651K ﹤0.01% 3485
2025
Q1 		$372K Buy
38,058
+12,333
+48% +$88.8K ﹤0.01% 3691
2024
Q4 		$139K Buy
25,725
+10,472
+69% +$65.6K ﹤0.01% 4088
2024
Q3 		$95.9K Sell
15,253
-34,574
-69% -$227K ﹤0.01% 4068
2024
Q2 		$315K Sell
49,827
-12,270
-20% -$83.4K ﹤0.01% 3679
2024
Q1 		$509K Buy
62,097
+523
+0.8% +$4.45K ﹤0.01% 3559
2023
Q4 		$514K Buy
61,574
+6,887
+13% +$61.4K ﹤0.01% 3530
2023
Q3 		$705K Buy
54,687
+1,053
+2% +$15.3K ﹤0.01% 3406
2023
Q2 		$857K Buy
+53,634
New +$856K ﹤0.01% 3420

Other funds holding NVCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
OCM
Occam Crest Management Darien, Connecticut $165M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BWP
Baldwin Wealth Partners Marion, Massachusetts $1.53B AUM 28.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Northern Trust's NVCT Position: Q1 2026 in Review

Northern Trust increased its Nuvectis Pharma (NVCT) stake by 6.7% in Q1 2026, buying an estimated $66.9K and bringing the position to 124,212 shares worth $960K. The position accounts for ﹤0.01% of the portfolio, ranked #3361.

Northern Trust first reported a position in NVCT in Q2 2023 and has held it in 12 quarters since. 62 funds tracked by Wall St. Rank hold NVCT as of Q1 2026.

  • Northern Trust held 124,212 shares of Nuvectis Pharma worth $960K as of Q1 2026.
  • Northern Trust bought 7,807 Nuvectis Pharma shares in Q1 2026, an estimated $66.9K.
  • Nuvectis Pharma made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #3361 holding.
  • Northern Trust first reported a position in Nuvectis Pharma in Q2 2023 and has held it in 12 quarters since.
  • 62 funds tracked by Wall St. Rank held Nuvectis Pharma as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.